Cancers Receives an Increased CiteScore of 8.0

We are pleased to inform you that Cancers (ISSN: 2072-6694) has received a heightened CiteScore of 8.0.

CiteScore provides transparent metrics that enable well-informed publishing strategies, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.

The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.

This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.

Cancers’ CiteScore ranks as follows:

• Q1 (81 out of 404) in the “Oncology” category;
• Q2 (72 out of 230) in the “Cancer Research” category. 

For more journal statistics, please visit https://www.mdpi.com/journal/cancers/stats.

Thank you to everyone who has contributed to the journal.